RPM INTERNATIONAL INC/DE/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that RPM INTERNATIONAL INC/DE/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | May 31, 2018 | $1.56B | Jul 23, 2018 |
| FY2018 | Feb 28, 2018 | $1.10B | Jul 23, 2018 |
| FY2018 | Nov 30, 2017 | $1.32B | Jul 23, 2018 |
| FY2018 | Aug 31, 2017 | $1.35B | Jul 23, 2018 |
| FY2018 | May 31, 2017 | $1.49B | Jul 23, 2018 |
| FY2018 | Feb 28, 2017 | $1.02B | Jul 23, 2018 |
| FY2018 | Nov 30, 2016 | $1.19B | Jul 23, 2018 |
| FY2018 | Aug 31, 2016 | $1.25B | Jul 23, 2018 |
| FY2018 | May 31, 2016 | $4.81B | Jul 23, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $7.37B | Jul 24, 2025 |
| FY2025 | May 31, 2024 | $7.34B | Jul 24, 2025 |
| FY2025 | May 31, 2023 | $7.26B | Jul 24, 2025 |
| FY2024 | May 31, 2022 | $6.71B | Jul 25, 2024 |
| FY2023 | May 31, 2021 | $6.11B | Jul 26, 2023 |
| FY2020 | May 31, 2020 | $1.46B | Jul 27, 2020 |
| FY2020 | Feb 29, 2020 | $1.17B | Jul 27, 2020 |
| FY2020 | Nov 30, 2019 | $1.40B | Jul 27, 2020 |
| FY2020 | Aug 31, 2019 | $1.47B | Jul 27, 2020 |
| FY2020 | May 31, 2019 | $1.60B | Jul 27, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | May 31, 2017 | $1.49B | Jul 24, 2017 |
| FY2017 | Feb 28, 2017 | $1.02B | Jul 24, 2017 |
| FY2017 | Nov 30, 2016 | $1.19B | Jul 24, 2017 |
| FY2017 | Aug 31, 2016 | $1.25B | Jul 24, 2017 |
| FY2017 | May 31, 2016 | $1.43B | Jul 24, 2017 |
| FY2017 | Feb 29, 2016 | $988.56M | Jul 24, 2017 |
| FY2017 | Nov 30, 2015 | $1.16B | Jul 24, 2017 |
| FY2017 | Aug 31, 2015 | $1.24B | Jul 24, 2017 |
| FY2016 | May 31, 2015 | $1.37B | Jul 28, 2016 |
| FY2016 | Feb 28, 2015 | $946.37M | Jul 28, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $3.05B | Jul 24, 2025 |
| FY2025 | May 31, 2024 | $3.01B | Jul 24, 2025 |
| FY2025 | May 31, 2023 | $2.75B | Jul 24, 2025 |
| FY2024 | May 31, 2022 | $2.43B | Jul 25, 2024 |
| FY2023 | May 31, 2021 | $2.41B | Jul 26, 2023 |
| FY2020 | May 31, 2020 | $553.96M | Jul 27, 2020 |
| FY2020 | Feb 29, 2020 | $434.75M | Jul 27, 2020 |
| FY2020 | Nov 30, 2019 | $529.40M | Jul 27, 2020 |
| FY2020 | Aug 31, 2019 | $574.75M | Jul 27, 2020 |
| FY2020 | May 31, 2019 | $635.81M | Jul 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $688.69M | Jul 24, 2025 |
| FY2025 | May 31, 2024 | $588.40M | Jul 24, 2025 |
| FY2025 | May 31, 2023 | $478.69M | Jul 24, 2025 |
| FY2024 | May 31, 2022 | $491.48M | Jul 25, 2024 |
| FY2023 | May 31, 2021 | $502.64M | Jul 26, 2023 |
| FY2020 | May 31, 2020 | $109.31M | Jul 27, 2020 |
| FY2020 | Feb 29, 2020 | $11.85M | Jul 27, 2020 |
| FY2020 | Nov 30, 2019 | $77.03M | Jul 27, 2020 |
| FY2020 | Aug 31, 2019 | $106.19M | Jul 27, 2020 |
| FY2020 | May 31, 2019 | $133.38M | Jul 27, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $94.70M | Jul 24, 2025 |
| FY2025 | May 31, 2024 | $92.20M | Jul 24, 2025 |
| FY2025 | May 31, 2023 | $86.60M | Jul 24, 2025 |
| FY2024 | May 31, 2022 | $80.50M | Jul 25, 2024 |
| FY2023 | May 31, 2021 | $77.60M | Jul 26, 2023 |
| FY2022 | May 31, 2020 | $76.50M | Jul 25, 2022 |
| FY2021 | May 31, 2019 | $71.60M | Jul 26, 2021 |
| FY2020 | May 31, 2018 | $69.70M | Jul 27, 2020 |
| FY2019 | May 31, 2017 | $64.90M | Jul 24, 2019 |
| FY2018 | May 31, 2016 | $61.50M | Jul 23, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $2.15B | Jul 24, 2025 |
| FY2025 | May 31, 2024 | $2.11B | Jul 24, 2025 |
| FY2025 | May 31, 2023 | $1.96B | Jul 24, 2025 |
| FY2024 | May 31, 2022 | $1.79B | Jul 25, 2024 |
| FY2023 | May 31, 2021 | $1.66B | Jul 26, 2023 |
| FY2022 | May 31, 2020 | $1.55B | Jul 25, 2022 |
| FY2021 | May 31, 2019 | $1.60B | Jul 26, 2021 |
| FY2020 | May 31, 2018 | $1.50B | Jul 27, 2020 |
| FY2019 | May 31, 2017 | $1.64B | Jul 24, 2019 |
| FY2018 | May 31, 2016 | $1.52B | Jul 23, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $768.19M | Jul 24, 2025 |
| FY2025 | May 31, 2024 | $1.12B | Jul 24, 2025 |
| FY2025 | May 31, 2023 | $577.11M | Jul 24, 2025 |
| FY2024 | May 31, 2022 | $178.73M | Jul 25, 2024 |
| FY2023 | May 31, 2021 | $766.16M | Jul 26, 2023 |
| FY2022 | May 31, 2020 | $549.92M | Jul 25, 2022 |
| FY2021 | May 31, 2019 | $292.94M | Jul 26, 2021 |
| FY2020 | May 31, 2018 | $390.38M | Jul 27, 2020 |
| FY2019 | May 31, 2017 | $386.13M | Jul 24, 2019 |
| FY2018 | May 31, 2016 | $474.71M | Jul 23, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $7.78B | Jul 24, 2025 |
| FY2025 | May 31, 2024 | $6.59B | Jul 24, 2025 |
| FY2024 | May 31, 2023 | $6.78B | Jul 25, 2024 |
| FY2024 | May 31, 2022 | $6.71B | Jul 25, 2024 |
| FY2023 | May 31, 2021 | $6.25B | Jul 26, 2023 |
| FY2022 | May 31, 2020 | $5.63B | Jul 25, 2022 |
| FY2021 | May 31, 2019 | $5.44B | Jul 26, 2021 |
| FY2020 | May 31, 2018 | $5.27B | Jul 27, 2020 |
| FY2019 | May 31, 2017 | $5.09B | Jul 24, 2019 |
| FY2018 | May 31, 2016 | $4.76B | Jul 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $2.89B | Jul 24, 2025 |
| FY2025 | May 31, 2024 | $2.51B | Jul 24, 2025 |
| FY2024 | May 31, 2023 | $2.14B | Jul 25, 2024 |
| FY2023 | May 31, 2022 | $1.98B | Jul 26, 2023 |
| FY2022 | May 31, 2021 | $1.74B | Jul 25, 2022 |
| FY2021 | May 31, 2020 | $1.26B | Jul 26, 2021 |
| FY2020 | May 31, 2019 | $1.41B | Jul 27, 2020 |
| FY2019 | May 31, 2018 | $1.63B | Jul 24, 2019 |
| FY2018 | May 31, 2017 | $1.44B | Jul 23, 2018 |
| FY2017 | May 31, 2016 | $1.37B | Jul 24, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $1.62B | Jul 24, 2025 |
| FY2025 | May 31, 2024 | $1.31B | Jul 24, 2025 |
| FY2025 | May 31, 2023 | $1.29B | Jul 24, 2025 |
| FY2024 | May 31, 2022 | $1.34B | Jul 25, 2024 |
| FY2023 | May 31, 2021 | $1.35B | Jul 26, 2023 |
| FY2022 | May 31, 2020 | $1.25B | Jul 25, 2022 |
| FY2021 | May 31, 2019 | $1.25B | Jul 26, 2021 |
| FY2020 | May 31, 2018 | $1.19B | Jul 27, 2020 |
| FY2019 | May 31, 2017 | $1.14B | Jul 24, 2019 |
| FY2018 | May 31, 2016 | $1.22B | Jul 23, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $3.19B | Jul 24, 2025 |
| FY2025 | May 31, 2024 | $2.76B | Jul 24, 2025 |
| FY2024 | May 31, 2023 | $2.40B | Jul 25, 2024 |
| FY2023 | May 31, 2022 | $2.14B | Jul 26, 2023 |
| FY2022 | May 31, 2021 | $1.85B | Jul 25, 2022 |
| FY2021 | May 31, 2020 | $1.54B | Jul 26, 2021 |
| FY2020 | May 31, 2019 | $1.43B | Jul 27, 2020 |
| FY2019 | May 31, 2018 | $1.34B | Jul 24, 2019 |
| FY2018 | May 31, 2017 | $1.17B | Jul 23, 2018 |
| FY2017 | May 31, 2016 | $1.15B | Jul 24, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $302.14M | Jul 24, 2025 |
| FY2025 | May 31, 2024 | $237.38M | Jul 24, 2025 |
| FY2024 | May 31, 2023 | $215.79M | Jul 25, 2024 |
| FY2023 | May 31, 2022 | $201.67M | Jul 26, 2023 |
| FY2022 | May 31, 2021 | $246.70M | Jul 25, 2022 |
| FY2021 | May 31, 2020 | $233.42M | Jul 26, 2021 |
| FY2020 | May 31, 2019 | $223.17M | Jul 27, 2020 |
| FY2019 | May 31, 2018 | $244.42M | Jul 24, 2019 |
| FY2019 | May 31, 2017 | $350.50M | Jul 24, 2019 |
| FY2019 | May 31, 2016 | $265.15M | Jul 24, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | May 31, 2013 | $1.37B | Jul 24, 2013 |
| FY2012 | May 31, 2012 | $1.12B | Jul 26, 2012 |
| FY2012 | May 31, 2011 | $1.11B | Jul 26, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 5 | Jul 24, 2025 |
| FY2025 | May 31, 2024 | 4 | Jul 24, 2025 |
| FY2025 | May 31, 2023 | 3 | Jul 24, 2025 |
| FY2024 | May 31, 2022 | 3 | Jul 25, 2024 |
| FY2023 | May 31, 2021 | 3 | Jul 26, 2023 |
| FY2020 | May 31, 2020 | 0 | Jul 27, 2020 |
| FY2020 | Feb 29, 2020 | 0 | Jul 27, 2020 |
| FY2020 | Nov 30, 2019 | 0 | Jul 27, 2020 |
| FY2020 | Aug 31, 2019 | 0 | Jul 27, 2020 |
| FY2020 | May 31, 2019 | 1 | Jul 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 5 | Jul 24, 2025 |
| FY2025 | May 31, 2024 | 4 | Jul 24, 2025 |
| FY2025 | May 31, 2023 | 3 | Jul 24, 2025 |
| FY2024 | May 31, 2022 | 3 | Jul 25, 2024 |
| FY2023 | May 31, 2021 | 3 | Jul 26, 2023 |
| FY2020 | May 31, 2020 | 0 | Jul 27, 2020 |
| FY2020 | Feb 29, 2020 | 0 | Jul 27, 2020 |
| FY2020 | Nov 30, 2019 | 0 | Jul 27, 2020 |
| FY2020 | Aug 31, 2019 | 0 | Jul 27, 2020 |
| FY2020 | May 31, 2019 | 1 | Jul 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 128.27M | Jul 24, 2025 |
| FY2025 | May 31, 2024 | 128.63M | Jul 24, 2025 |
| FY2024 | May 31, 2023 | 128.77M | Jul 25, 2024 |
| FY2023 | May 31, 2022 | 129.20M | Jul 26, 2023 |
| FY2022 | May 31, 2021 | 129.57M | Jul 25, 2022 |
| FY2021 | May 31, 2020 | 129.51M | Jul 26, 2021 |
| FY2020 | May 31, 2019 | 131.00M | Jul 27, 2020 |
| FY2019 | May 31, 2018 | 133.65M | Jul 24, 2019 |
| FY2018 | May 31, 2017 | 133.56M | Jul 23, 2018 |
| FY2017 | May 31, 2016 | 132.94M | Jul 24, 2017 |